Warning letters / Biologics
FDA warning letter to
Issued Aug 3, 2022Posted Aug 9, 2022Center for Biologics Evaluation and Research (CBER)
Bioresearch Monitoring Program. We haven't summarized this letter yet. Read it on fda.gov.